Triticum vulgare para el tratamiento del síndrome genitourinario de la menopausia, Armenia, Colombia / Triticum vulgare for the treatment of genitourinary syndrome of menopause, Armenia, Colombia

OBJETIVO: Evaluar la eficacia y la seguridad de Triticum vulgare en el tratamiento del síndrome genitourinario de la menopausia (SGUM). MÉTODO: Estudio cuasiexperimental (antes-después, con grupo control) en mujeres posmenopáusicas (amenorrea ≥ 36 meses, hormona estimulante del folículo > 40 U/l y estradiol < 25 pg/ml), sexualmente activas, con un índice de maduración vaginal (IMV) < 50 y pH ≥ 5, citología cervical negativa (Papanicolaou) y diagnóstico de SGUM, atendidas en el programa de climaterio y menopausia de una clínica privada de mediana complejidad, en Armenia, Quindío (Colombia). Se seleccionaron 207 mujeres con edad promedio de 55,19 ± 7,28 años. Se realizó un muestreo consecutivo. Se asignaron dos grupos: A (n = 105), que recibió T. vulgare, y B (n = 102), que recibió placebo. Se hizo seguimiento al inicio (basal) y 4, 8 y 12 semanas después, utilizando el IMV y el Índice de Función Sexual Femenina (IFSF). Los síntomas del SGUM se evaluaron con una escala visual analógica (EVA). Se aplicó estadística descriptiva. RESULTADOS: La puntuación media del IMV fue mayor en las semanas 4, 8 y 12 en todas las mujeres del grupo A (p = 0,01). Se observó una diferencia significativa en el promedio final de la puntuación del IMV de T. vulgare frente al placebo (p < 0,05). Al final del estudio, el grupo A mostró una mejoría significativa en la puntuación promedio del IFSF, en comparación con el grupo B (p < 0,001). Las puntuaciones de la EVA presentaron una disminución progresiva a lo largo del estudio, pero fueron comparables entre los dos grupos (p = 0,813). CONCLUSIONES: T. vulgare es una efectiva, segura e innovadora alternativa, no hormonal, para el tratamiento del SGUM. No se registraron eventos adversos, por lo que se demostró su seguridad.

OBJECTIVE: To evaluate the efficacy and safety of Triticum vulgare in the treatment of genitourinary syndrome of menopause. METHOD: Quasi-experimental study (before-after, with control group) in postmenopausal women (amenorrhea ≥ 36 months, FSH > 40 U/L and estradiol < 25 pg/ml), sexually active, with a vaginal maturation index (VMI) < 50 and pH ≥ 5, negative cervical cytology (Papanicolaou) and with a diagnosis of genitourinary syndrome of menopause (SGUM); who were treated in the climacteric and menopause program of a private clinic of medium complexity, in Armenia, Quindío (Colombia). 207 participants were selected, with a mean age of 55.19 ± 7.28 years. A consecutive sampling was carried out. Two groups were assigned: A (n = 105) with T. vulgare and B (n = 102) with placebo. Follow-up was done at baseline (baseline), four, eight and twelve weeks later, using the VMI and the female sexual function index (IFSF). Symptoms of SGUM were evaluated using a visual analog scale (VAS). Descriptive statistics were applied. RESULTS: The mean score of the IMV was higher in weeks 4, 8 and 12 in all the participants of group A (p = 0.01). A significant difference was observed in the final mean MVI score of T. vulgare versus placebo (p < 0.05). At the end of the study, group A showed a significant improvement in the mean IFSF score, compared to placebo (p < 0.001). The VAS scores showed a progressive decrease throughout the study but were comparable between the two groups (p = 0.813). CONCLUSIONS: T. vulgare is an effective, safe and innovative non-hormonal alternative for the treatment of SGUM. No adverse events were recorded, guaranteeing their safety.

Prurito Vulvar y Enfermedad de Fox ­ Fordyce, un reporte de caso / Fox - Fordyce Disease, A Case Report

Se presenta un caso infrecuente de enfermedad de Fox-Fordyce en región vulvar, una dermatosis inflamatoria no infecciosa, infrecuente, de glándulas apocrinas, caracterizada por una erupción papular pruriginosa que involucra vulva, axila y región perianal, a predominio del sexo femenino, del cual no hay reportes nacionales. Se presenta una paciente de 53 años de edad, evaluada en consulta de ginecobstetricia, por presentar desde hace 5 meses, erupción papular en zona vulvar, asociado a prurito intermitente. Se tomó una biopsia de la lesión, y se envió al servicio de anatomía patológica, recibiéndose un fragmento de tejido de color pardo oscuro, de 0,3 x 0,2 x 0,1cm, en la cual se evidenció glándulas apocrinas dilatadas, con secreción espesa constituida por mucina, en su luz. Cumpliendo con los criterios histopatológicos, se estableció el diagnóstico de Enfermedad de Fox ­ Fordyce. Se consideró importante la presentación de este caso debido a la naturaleza infrecuente de esta enfermedad.

Fox-Fordyce disease is a non-infectious, infrequent inflammatory dermatosis of apocrine glands, isolated by a pruritic papular rash that usually begins frequently at puberty, and which may involve vulva, armpit and perianal region. It affects women more frequently, approximately in a 9 to 1 ratio, compared to men. In the presentation of the case of a female patient, 53 years old, in consultation of Gynecology-Obstetrics, of the General Maria Auxiliadora Hospital, for presenting for 5 months, papular eruption in vulvar area, associated with intermittent pruritus. A biopsy of the lesion was requested, and it was sent to the Pathological Anatomy Service, receiving a fragment of dark brown tissue, 0.3 x 0.2 x 0.1cm, which was automatically processed, obtaining a histological sheet, in which evidence dilated apocrine glands, which show a thick secretion made up of mucin, in its light. The patient met the histopathological criteria for the diagnosis of Fox - Fordyce disease. Consider the case presentation because of the infrequent nature of this disease.

Clinical analysis of 129 cases of vulvar lichen sclerosus / 中华皮肤科杂志

Objective To investigate clinical features of vulvar lichen sclerosus (VLS).Methods Clinical data were collected from patients with VLS in Department of Dermatology of Beijing Hospital,and analyzed retrospectively with respect to age,duration of disease,medical history,complications,clinical symptoms and signs,and features of skin lesions.Results A total of 129 patients with VLS were enrolled into this study from March 2016 to February 2017.The age of onset in these patients presented a normal distribution,with the highest frequency at the age range of 25-30 years.Of the 129 patients,only 18 (14％) developed VLS after menopause,and 12 (9.3％) were complica1ed by autoimmune diseases,especially thyroid diseases.Pruritus was reported as the main symptom in 122 (94.6％) of the 129 patients,and 51 (60％) reported that their sexual life had been affected.Labia minora was the most commonly involved site in 92 (71.3％)patients,but unilateral labia majus was rarely involved.The most common skin lesion was hypopigmentation (92.2％,119/129),followed by lichenification (55.0％,71/129) and skin atrophy (40.3％,52/129).Patients with skin atrophy had significantly longer duration of disease than those without skin atrophy (Z =3.124,P =0.002),and the incidence of skin atrophy was lower in the patients who had been treated with topical glucocorticoids or calcineurin inhibitors than those who had not received these treatment (x2 =5.074,P =0.024).Conclusions VLS is more common in women of childbearing age than in postmenopausal women,and basically characterized by pruritus and hypopigmentation.VLS commonly involves bilateral labia minora,and usually affects sexual life.

Extramammary Paget Disease of the Vulva - Case Report / Relato de Caso: Doença de Paget Extramamária da Vulva

Abstract Extramammary Paget disease (EPD) is a rare malign neoplasm that may affect the vulva and has manifestations common to benign diseases such as itching, pain and eczema. This leads to delay in diagnosis and consequent worse prognosis. The definitive diagnosis is obtained by biopsy of the vulva, which shows Paget cells. The treatment of choice is wide excision with margins, which leads to sequelae, functional and aesthetic. Recurrence is common. This article reports the case of a 48-year-old female patient with history of vulvar itching for the past 2 years, who had been submitted to various treatments for benign pathologies. The patient was biopsied and was diagnosed with extensive EPD, being submitted to vulvectomy. This article aims to draw attention to the need for biopsy of pruritic vulvar lesions that do not respond to usual treatment.

Resumo A doença de Paget extramamária (DPEM) é uma neoplasia maligna incomum que pode acometer a vulva, e que tem manifestações comuns a doenças benignas como prurido, dor e eczema. Isto leva a atraso no diagnóstico e, consequente, piora do prognóstico. O diagnóstico de certeza se dá pela biópsia de vulva que evidencia células de Paget. O tratamento de escolha é a excisão com margens amplas, que leva a sequela funcional e estética. A recidiva é frequente. Este artigo relata o caso de uma paciente do sexo feminino, de 48 anos, com história de prurido vulvar há 2 anos com diversos tratamentos para patologias benignas. A biopsia da paciente confirmou diagnóstico de DPEM extensa sendo submetida a vulvectomia. Este artigo visa chamar a atenção para a necessidade de biópsia das lesões vulvares pruriginosas que não respondem ao tratamento habitual.

Vulvodínia: diagnóstico e tratamento / Vulvodynia: diagnosis and treatment

A vulvodínia é uma condição de desconforto vulvar crônico que afeta milhares de mulheres a cada ano. Trata-se de síndrome multifatorial com grande impacto na qualidade de vida das mulheres afetadas. Seu tratamento representa atualmente um desafio para o médico assistente que, apesar de estar mais atento ao seu diagnóstico, ainda não encontra evidências científicas para tratamento dessas pacientes. Ainda não é possível encontrar revisões sistemáticas ou metanálises pela heterogeneidade dos artigos. A abordagem multidisciplinar parece trazer melhores resultados. Habitualmente essas mulheres passam por vários especialistas à procura de alívio dos seus sintomas, na maioria das vezes sem sucesso. Este artigo objetiva fazer uma revisão atualizada do diagnóstico e tratamento da vulvodínia para orientar a prática clínica.(AU)

Vulvodynia is a vulvar discomfort and chronic condition that affects millions of women each year. It is a multifactorial syndrome with great impact on the quality of life of women affected by it. Its treatment is currently a challenge for the physician. Despite being closer to the diagnosis, scientific evidence for treating these patients has not yet been found. Systematic reviews and meta-analysis cannot be found due to the heterogeneity of the articles. A multidisciplinary approach seems to bring the best results. Usually these women consult several specialists seeking relief of their symptoms, most of the time without success. The aim of this article is to review the current diagnosis and treatment of vulvodynia to guide clinical practice.(AU)

Conduta na dor e prurido vulvar / Pain and pruritus vulvae management

Prurido e dor são as principais manifestações clínicas das doenças vulvares. Estes sintomas podem estar associados a processos inflamatórios, imunológicos, distúrbios metabólicos e neoplasias. Na dúvida, é sempre recomendável o estudo histopatológico. Quando não há definição etiológica, várias opções terapêuticas estão disponíveis: cremes tópicos, fármacos sistêmicos, operações de dessensibilização nervosa da vulva. A conduta terapêutica deve ser individualizada quando não há etiologia definida. São escassos os trabalhos científicos, com metodologia adequada, que abordam o tema. Portanto, anamnese e exame físico cuidadosos irão definir a melhor abordagem terapêutica

Pruritus and pain are common manifestations of vulvae diseases. The symptoms can be associated with inflammatory, immunologic, metabolic or neoplastic diseases. Undoubtedly, the histopathological exam is always recommended. When there is no etiologic definition, many therapeutic options are available: creams, systemic drugs, and surgical neural desensitization of the vulvae. When there is no precise etiology, therapeutical approach must be individualized. Scientific studies, with good methodology, are rare. Therefore, careful anamnesis and physical exam will point to the best therapeutical approach

Leucoplakia vulvae

1) Fifteen cases of leucoplakia of the vulva among Filipinos are presented, with an incidence of 0.3% during a six-year period2) The disease is most frequent in the fourth, fifth, and sixth decades of life, the majority of the patients being near or past the menopause3) The duration of the symptoms before patients seek medical advise is notoriously long, an average of 6.3 years4) Pruritus vulvae is the most prominent and constant symptom5) Carcinoma coexisted with every fourth case of leucoplakia vulvae6) Complete vulvectomy was the operation of choice. (Summary)

A Case of Vulvar Syringoma Mimicking Pruritus Vulvae / 대한피부과학회지

We rep a case of vulvar syringoma in a 32-year-old woman who had pruritus vulvae for 2 years. An examination of both the labia major revealed slightly thickened hyperpigmented or hypopigmented patches without yellow papules. A skin punch biopsy revealed characteristic histological findings of syringoma. Syringoma of the vulva is a rare disorder and is usually asymptomatic. Five cases of vulvar syringoma preriously reported in the Korean literature all had asymptomatic yellow or brown colored papules, but this case presented here was clinically considered as pruritus vulvae.

Clinical Trial of Fubishu Capsule for External Application in the Treatment of Pruritus Vulvae / 中药新药与临床药理

0.05).Conclusion It is effective an d safety to use Fubishu capsule for external application in treating pruritus vu lvae with the syndrome of damp- heat; no obvious adverse reactions occurs durin g the clinical trial.